2006
DOI: 10.1016/j.ajem.2005.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(15 citation statements)
references
References 22 publications
0
15
0
Order By: Relevance
“…A number of researchers have studied the clinical drug administration effects of heliox-driven aerosol over the recent years, while the findings were strikingly different [8]. Findings from some studies support the benefits of heliox-driven aerosol [9,10], whereas other studies have not found clinical benefits from the use of heliox [11,12]. Moreover, the treatment effects were obviously different with different proportions of oxygen and helium.…”
Section: Introductionmentioning
confidence: 99%
“…A number of researchers have studied the clinical drug administration effects of heliox-driven aerosol over the recent years, while the findings were strikingly different [8]. Findings from some studies support the benefits of heliox-driven aerosol [9,10], whereas other studies have not found clinical benefits from the use of heliox [11,12]. Moreover, the treatment effects were obviously different with different proportions of oxygen and helium.…”
Section: Introductionmentioning
confidence: 99%
“…In one study, patients aged 3-16 years who had received three nebulized albuterol doses plus intravenous methyprednisolone were randomly assigned to receive 70:30 heliox (20 patients) or 70:30 N 2 :O 2 (21 patients) for the continuous nebulization of albuterol 0.45 mg/kg (maximum dosage 15 mg/hr). 29 No difference was seen in a modified dyspnea index score at 10 or 20 minutes. In the other study, 30 children aged 2-18 years with moderate-to-severe asthma were randomly assigned to continuous nebulization of albuterol 15 mg/hour by 70:30 heliox or oxygen.…”
Section: Discussionmentioning
confidence: 89%
“…63 Some studies have shown modest benefit [63][64][65] whereas others show no benefit. 66 It has a level D recommendation as the driver of nebulized salbutamol in severe asthma, 3 mainly because of its lack of side effects.…”
Section: Second-line Treatmentsmentioning
confidence: 99%